NPC1 and nasopharyngeal carcinoma: To examine whether G2-β-CD has therapeutic potential against NPC pathology, we evaluated the effects of G2-β-CD on intracellular cholesterol levels and lysosome volume in Npc1 deficient CHO cells using a previously reported method [19].